GENinCode on Tuesday reported a larger annual loss as cost of sales and administrative expenses ballooned.
The biotechnology company focused on prevention of cardiovascular disease said pretax loss. | June 6, 2023
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
GENinCode PLC - biotechnology company focused on prevention. | April 3, 2023